STAT

More trial results are being posted to public database, but data quality is lacking, report finds

A new report finds more clinical trial results are being posted to public federal database, but data quality is lacking.

A new report examining the first decade of study results being reported on ClinicalTrials.gov finds that there has been slow progress among drug companies and academic research centers in reporting the results of human studies, but the quality of the data may still present a larger problem.

When the database was expanded through federal law in 2008 to accommodate clinical trial results, an average of two trials per week posted results, even though 79 trials were completed every week. In 2018, that figure rose to 68 trials with results posted out of 135 completed trials, according to the research, published Wednesday in the New England Journal of Medicine.

“It’s a bit disappointing that it’s not higher,” said Georgina Humphreys, clinical data sharing officer for Wellcome Open Research in the U.K., who was not involved in the

You’re reading a preview, subscribe to read more.

More from STAT

STAT1 min readIntelligence (AI) & Semantics
STAT+: Q&A: Defining Responsible AI In Health Care, With CHAI CEO Brian Anderson
CHAI CEO Anderson wants to build public trust in AI and empower patients and providers to have more informed conversations.
STAT2 min read
STAT+: Pharmalittle: We’re Reading About FDA Approval For Sarepta Drug, MSF Closing Access Campaign And More
After months of haggling, Vertex Pharmaceuticals and the National Health Service in England reached agreement over access to several cystic fibrosis treatments, capping an end to a controversial, long-running saga:
STAT2 min read
STAT+: Pharmalittle: We’re Reading About EMA Plans For GLP-1 Shortages, Walgreens Store Closings, And More
The European Medicines Agency and member countries announced several steps to address shortages of GLP-1 drugs.

Related Books & Audiobooks